Status:
COMPLETED
Pre-operative Risk Assessment of Surgical Site Infection After Cardiac Surgery
Lead Sponsor:
Barts & The London NHS Trust
Collaborating Sponsors:
Liverpool Heart and Chest Hospital NHS Foundation Trust
University Hospitals, Leicester
Conditions:
Surgical Site Infection
Risk Assessment
Eligibility:
All Genders
18-120 years
Brief Summary
Surgical site infections (SSI) are serious complications accounting for 20% of all the healthcare-associated infections and are considered the second most frequent type of hospital-acquired infection ...
Detailed Description
Surgical site infections (SSI) are serious complications accounting for 20% of all the healthcare-associated infections and are considered the second most frequent type of hospital-acquired infection ...
Eligibility Criteria
Inclusion
- \>/= 18 years old at the time of surgery; and
- had a primary surgery (CABG, valve surgery or both) in the UK cardiac centres.
Exclusion
- patients undergoing grown-up congenital heart disease related surgery;
- patients with concurrent aortovascular surgery;
- patients who had ventricular-assist device (VAD), haemolung, impellar and/or extracorporeal membrane oxygenator (ECMO) before and/or after cardiac surgery;
- patients who had an open-chest immediately after surgery.
Key Trial Info
Start Date :
July 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
6379 Patients enrolled
Trial Details
Trial ID
NCT04762446
Start Date
July 15 2022
End Date
November 30 2023
Last Update
April 10 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Liverpool Heart and Chest Hospital
Liverpool, United Kingdom
2
James Cook University Hospital
Middlesbrough, United Kingdom
3
Oxford University Hospital
Oxford, United Kingdom